Oligonucleotide Therapeutics: New Drugs That Could Stop COVID-19

This webinar is suggested for nonscientists who are not familiar with oligonucleotides, but who are interested in learning how new biotechnologies can help to stop this pandemic.

Starting with the biology basics, Dr. Art Krieg, Past President of the Oligonucleotide Therapeutics Society, explains what oligonucleotide therapeutics are, and some of the life-saving drugs that have been developed.

The focus then is on the application of these technologies to prevent or treat Covid-19, including the vaccines that are now in the news, and explaining the way they work based on general scientific principles that should be familiar to most people.

A key point made is the speed with which the new generations of oligonucleotide drugs (including mRNA and DNA vaccines) can be developed against a novel pandemic such as this.

OTS members may find this webinar helpful for their family members who don't understand what they are doing and why it is important!

OTS Resources:

[aminalolol]

wow, thank you so much I've learned a lot thru this video!
Good luck with the development of your youtube channel!

[annwynehouldsworth]

A very clearly explained production. Exciting prospects for future prevention of viral pandemics.

[annwynehouldsworth]

Have you heard about Jesse Gelsinger in 1999 from Arizona, who had a rare metabolic disorder called ornithine transcarbamylase deficiency syndrome (OTCD) in a milder disease form? He was the 18th person to receive the gene therapy but died four days after initiating the treatment. This event dashed many hopes of a miraculous genetic cure because of the unexpected response to the gene delivery. Thus trial eligibility criteria is essential to success of the success of the new therapy.